SNCE logo

Science 37 Holdings, Inc. Stock Price

NasdaqCM:SNCE Community·US$34.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SNCE Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

SNCE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with excellent balance sheet.

5 Risks
3 Rewards

Science 37 Holdings, Inc. Key Details

US$60.3m

Revenue

US$38.1m

Cost of Revenue

US$22.1m

Gross Profit

US$146.8m

Other Expenses

-US$124.7m

Earnings

Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
-20.67
36.71%
-206.85%
0%
View Full Analysis

About SNCE

Founded
2014
Employees
460
CEO
David Coman
WebsiteView website
www.science37.com

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company’s platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Recent SNCE News & Updates

Recent updates

No updates